N-(2,2,4,4-Tetramethyl-thiochroman-6-yl)-terephthalamic acid methyl ester

ID: ALA139536

PubChem CID: 11740691

Max Phase: Preclinical

Molecular Formula: C22H25NO3S

Molecular Weight: 383.51

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC(=O)c1ccc(C(=O)Nc2ccc3c(c2)C(C)(C)CC(C)(C)S3)cc1

Standard InChI:  InChI=1S/C22H25NO3S/c1-21(2)13-22(3,4)27-18-11-10-16(12-17(18)21)23-19(24)14-6-8-15(9-7-14)20(25)26-5/h6-12H,13H2,1-5H3,(H,23,24)

Standard InChI Key:  JZHWLPKXASYCHY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    2.8042   -5.1417    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.3167   -4.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8000   -3.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3167   -4.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3917   -4.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2875   -4.8417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8750   -3.9292    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4667   -3.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2792   -4.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9125   -3.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9500   -3.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8375   -3.9375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3542   -4.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3917   -4.8292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9875   -3.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8375   -5.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9042   -3.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4292   -4.2292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9500   -3.9292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4250   -3.0292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3542   -4.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4625   -2.4250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2792   -3.6417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2167   -3.5167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1292   -5.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6875   -4.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9792   -2.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  4  2  0
  3  9  1  0
  4  1  1  0
  5  7  1  0
  6  1  1  0
  7 13  1  0
  8 11  1  0
  9  6  1  0
 10  5  1  0
 11 19  2  0
 12  2  1  0
 13 21  1  0
 14  5  2  0
 15  8  2  0
 16  4  1  0
 17 10  1  0
 18 10  2  0
 19 18  1  0
 20 17  2  0
 21 16  2  0
 22  8  1  0
 23  3  1  0
 24  3  1  0
 25  6  1  0
 26  6  1  0
 27 22  1  0
  2  3  1  0
 13 12  2  0
 20 11  1  0
M  END

Associated Targets(Human)

SCC-38 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARA Tclin Retinoic acid receptor alpha (1324 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARB Tclin Retinoic acid receptor beta (1232 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARG Tclin Retinoic acid receptor gamma (1154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SCC-2 (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rxra Retinoid X receptor alpha (88 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rxrb Retinoid X receptor beta (158 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rxrg Retinoid X receptor gamma (155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.51Molecular Weight (Monoisotopic): 383.1555AlogP: 5.28#Rotatable Bonds: 3
Polar Surface Area: 55.40Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.15CX LogD: 5.15
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.73Np Likeness Score: -0.65

References

1. Zacheis D, Dhar A, Lu S, Madler MM, Klucik J, Brown CW, Liu S, Clement F, Subramanian S, Weerasekare GM, Berlin KD, Gold MA, Houck JR, Fountain KR, Benbrook DM..  (1999)  Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.,  42  (21): [PMID:10543887] [10.1021/jm990292i]

Source